A randomized, multicenter, parallel-group, open-label study to assess the efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic®) versus continuation of previous therapy in patients with proliferative lupus nephritis on standard maintenance therapy

Trial Profile

A randomized, multicenter, parallel-group, open-label study to assess the efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic®) versus continuation of previous therapy in patients with proliferative lupus nephritis on standard maintenance therapy

Recruiting
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Mycophenolate sodium; Prednisone
  • Indications Lupus nephritis
  • Focus Therapeutic Use
  • Acronyms MyLupus
  • Sponsors Novartis Pharma A.G.
  • Most Recent Events

    • 01 Jun 2011 New Source Identified - European Clinical Trials Database.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top